Even Pro Traders Love This Simple 9-Month Millionaire System

For three years straight, it’s worked... Wall Street insider Bryan Perry has used everyday investors to beta test his simple millionaire maker system.

The results? Year one: $1.07 million in 9 months... Year two: $1.04 million in 9 months... And, in year three, a stunning $1.17 million in just 8 months.

He’s just announced his fourth and final beta test.

Only 87 new traders will be accepted.

Click here to apply for his fourth and final beta-test round.

BEAM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $11,733,541.63

Beam Therapeutics Insider Trading History Chart

Beam Therapeutics Share Price & Price History

^$24.05

▲ +0.03 (0.12%)

As of 09/29/2023 01:00 AM ET

Days: 30 | 90 | 365

Free Stock Analysis Report: See The True Value of Any Stock

From Vector Vest | Ad

Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.

Analyze Any Stock Free

Beam Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/24/2023	Giuseppe Ciaramella	Insider	Sell	1,206	$32.01	$38,604.06	48,250
7/21/2023	Giuseppe Ciaramella	Insider	Sell	155,324	$32.06	$4,979,687.44	48,250
7/10/2023	Amy Simon	Insider	Sell	391	$30.48	$11,917.68	68,917
4/3/2023	Giuseppe Ciaramella	Insider	Sell	1,918	$30.31	$58,134.58	114,044
4/3/2023	John M Evans	CEO	Sell	5,161	$30.31	$156,429.91	1,124,472
4/3/2023	Terry-Ann Burrell	CFO	Sell	2,454	$30.31	$74,380.74	49,303
1/26/2023	Terry-Ann Burrell	CFO	Sell	1,102	$45.16	$49,766.32	31,277
1/24/2023	Terry-Ann Burrell	CFO	Sell	14,810	$45.01	$666,598.10	31,277
1/18/2023	Terry-Ann Burrell	CFO	Sell	47,195	$45.14	$2,130,382.30	31,277
12/12/2022	Giuseppe Ciaramella	Insider	Sell	51,015	$42.70	$2,178,340.50	91,462
10/31/2022	John M Evans	CEO	Sell	30,000	$46.31	$1,389,300.00	1,058,520
8/5/2022	Fmr Llc	Insider	Sell	20,326	$60.50	$1,229,723.00
7/28/2022	John M Evans	CEO	Sell	30,000	$65.75	$1,972,500.00	1,088,520
4/28/2022	John M Evans	CEO	Sell	30,000	$37.98	$1,139,400.00	1,118,520
4/13/2022	Fmr Llc	Insider	Sell	19,466	$50.41	$981,281.06
3/31/2022	Giuseppe Ciaramella	Insider	Sell	1,859	$59.11	$109,885.49	115,614
3/31/2022	John M Evans	CEO	Sell	6,261	$59.11	$370,087.71	1,089,070
3/31/2022	Terry-Ann Burrell	CFO	Sell	1,787	$59.11	$105,629.57	38,278
12/21/2021	Giuseppe Ciaramella	Insider	Sell	25,104	$85.69	$2,151,161.76
10/6/2021	John M Evans	CEO	Sell	27,700	$83.80	$2,321,260.00
8/19/2021	John M Evans	CEO	Sell	20,000	$99.49	$1,989,800.00
7/7/2021	John M. Evans	CEO	Sell	25,000	$107.87	$2,696,750.00	1,046,525
7/6/2021	Graham K Cooper	Director	Sell	2,614	$120.61	$315,274.54
6/30/2021	Terry-Ann Burrell	CFO	Sell	30,000	$122.00	$3,660,000.00
6/28/2021	Giuseppe Ciaramella	Insider	Sell	78,580	$107.35	$8,435,563.00	123,341
6/28/2021	Graham K Cooper	Director	Sell	12,045	$106.34	$1,280,865.30	12,045
6/28/2021	Terry-Ann Burrell	CFO	Sell	45,000	$107.69	$4,846,050.00	69,809
4/21/2021	John M Evans	CEO	Sell	25,000	$70.49	$1,762,250.00	1,038,966

Free Stock Analysis Report: See The True Value of Any Stock

From Vector Vest | Ad

Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.

Analyze Any Stock Free

SEC Filings (Institutional Ownership Changes) for Beam Therapeutics (NASDAQ:BEAM)

80.64% of Beam Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Beam Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/21/2023	Barclays PLC	144,532	$4.62M	0.0%	+25.0%	0.182%
8/22/2023	Virginia Retirement Systems ET AL	15,900	$0.51M	0.0%	N/A	0.020%
8/21/2023	California State Teachers Retirement System	73,697	$2.35M	0.0%	+0.7%	0.093%
8/16/2023	Nuveen Asset Management LLC	171,084	$5.46M	0.0%	-14.9%	0.216%
8/15/2023	Alliancebernstein L.P.	89,530	$2.86M	0.0%	+27.7%	0.113%
8/15/2023	Wells Fargo & Company MN	85,649	$2.74M	0.0%	+43.8%	0.108%
8/15/2023	XTX Topco Ltd	8,779	$0.28M	0.1%	+20.9%	0.011%
8/15/2023	Goldman Sachs Group Inc.	726,025	$23.18M	0.0%	+10.3%	0.917%
8/15/2023	Royal Bank of Canada	23,337	$0.75M	0.0%	+6.4%	0.029%
8/14/2023	Mercer Global Advisors Inc. ADV	9,594	$0.31M	0.0%	+22.5%	0.012%
8/14/2023	Tudor Investment Corp Et Al	6,821	$0.22M	0.0%	N/A	0.009%
8/14/2023	Tower Research Capital LLC TRC	11,419	$0.37M	0.0%	+101.7%	0.014%
8/14/2023	Schonfeld Strategic Advisors LLC	74,904	$2.39M	0.0%	+119.9%	0.095%
8/14/2023	State of Wisconsin Investment Board	49,515	$1.58M	0.0%	-4.9%	0.063%
8/14/2023	State Street Corp	3,587,004	$114.53M	0.0%	+10.8%	4.529%
8/14/2023	Deep Track Capital LP	1,317,316	$42.06M	1.9%	+5.4%	1.663%
8/14/2023	Nuveen Asset Management LLC	171,084	$5.46M	0.0%	-14.9%	0.216%
8/14/2023	Temasek Holdings Private Ltd	4,317,789	$137.87M	0.8%	+5.5%	5.452%
8/11/2023	Credit Suisse AG	96,045	$3.07M	0.0%	+23.0%	0.121%
8/11/2023	BlackRock Inc.	6,350,776	$202.78M	0.0%	+20.0%	8.019%
8/11/2023	Ameritas Investment Partners Inc.	5,643	$0.18M	0.0%	+13.2%	0.007%
8/11/2023	State Board of Administration of Florida Retirement System	19,400	$0.62M	0.0%	-2.6%	0.024%
8/11/2023	The Manufacturers Life Insurance Company	27,407	$0.88M	0.0%	+7.9%	0.035%
8/11/2023	Hsbc Holdings PLC	33,722	$1.09M	0.0%	+106.4%	0.043%
8/11/2023	Schroder Investment Management Group	156,405	$4.99M	0.0%	-39.6%	0.197%
8/11/2023	Guggenheim Capital LLC	86,342	$2.76M	0.0%	+6.3%	0.109%
8/11/2023	Geode Capital Management LLC	1,324,175	$42.28M	0.0%	+10.1%	1.672%
8/11/2023	Sei Investments Co.	7,142	$0.23M	0.0%	N/A	0.009%
8/11/2023	E Fund Management Co. Ltd.	13,867	$0.44M	0.0%	+15.4%	0.018%
8/11/2023	D.A. Davidson & CO.	18,224	$0.58M	0.0%	+14.2%	0.023%
8/11/2023	JPMorgan Chase & Co.	707,680	$22.60M	0.0%	-2.0%	0.894%
8/11/2023	Penserra Capital Management LLC	7,755	$0.25M	0.0%	+22.1%	0.010%
8/11/2023	Northern Trust Corp	624,962	$19.96M	0.0%	+2.8%	0.789%
8/10/2023	Kraematon Investment Advisors Inc.	7,915	$0.25M	0.3%	N/A	0.010%
8/10/2023	MetLife Investment Management LLC	36,030	$1.15M	0.0%	+7.9%	0.047%
8/10/2023	Osaic Holdings Inc.	13,112	$0.42M	0.0%	-3.0%	0.017%
8/10/2023	ProShare Advisors LLC	13,820	$0.44M	0.0%	+6.8%	0.018%
8/10/2023	Profund Advisors LLC	47,154	$1.51M	0.1%	+18.8%	0.062%
8/10/2023	Commonwealth Equity Services LLC	8,782	$0.28M	0.0%	+11.6%	0.012%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	294,773	$9.41M	0.0%	+29.9%	0.387%
8/10/2023	Russell Investments Group Ltd.	116,360	$3.72M	0.0%	+7.0%	0.153%
8/10/2023	Charles Schwab Investment Management Inc.	501,420	$16.01M	0.0%	+8.2%	0.658%
8/9/2023	Dimensional Fund Advisors LP	284,626	$9.09M	0.0%	+57.8%	0.373%
8/9/2023	Swiss National Bank	126,100	$4.03M	0.0%	+3.6%	0.165%
8/9/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	7,931	$0.25M	0.0%	N/A	0.010%
8/8/2023	Rhumbline Advisers	95,084	$3.04M	0.0%	+8.1%	0.125%
8/8/2023	Candriam S.C.A.	129,665	$4.14M	0.0%	+62.8%	0.170%
8/7/2023	Principal Financial Group Inc.	17,326	$0.55M	0.0%	+2.5%	0.023%
8/4/2023	Envestnet Asset Management Inc.	15,241	$0.49M	0.0%	+18.5%	0.020%
8/4/2023	American International Group Inc.	32,893	$1.05M	0.0%	+7.2%	0.043%
8/4/2023	Contrarius Investment Management Ltd	113,364	$3.62M	0.2%	N/A	0.149%
8/3/2023	Los Angeles Capital Management LLC	26,849	$0.86M	0.0%	+19.1%	0.035%
8/3/2023	Barclays PLC	144,532	$4.62M	0.0%	+25.0%	0.190%
8/3/2023	CWM LLC	27,442	$0.88M	0.0%	-4.0%	0.036%
8/3/2023	Bank of New York Mellon Corp	481,856	$15.39M	0.0%	+1.1%	0.632%
8/3/2023	Steel Peak Wealth Management LLC	9,359	$0.30M	0.0%	-9.9%	0.012%
8/2/2023	State of New Jersey Common Pension Fund D	75,104	$2.40M	0.0%	+32.1%	0.099%
8/2/2023	Handelsbanken Fonder AB	10,500	$0.34M	0.0%	+11.7%	0.014%
7/31/2023	LPL Financial LLC	28,019	$0.90M	0.0%	+19.3%	0.037%
7/31/2023	Sumitomo Mitsui Trust Holdings Inc.	1,215,080	$38.80M	0.0%	+84.5%	1.594%
7/28/2023	Baillie Gifford & Co.	523,733	$16.72M	0.0%	+15.7%	0.687%
7/24/2023	Allspring Global Investments Holdings LLC	2,506	$80K	0.0%	+29.7%	0.003%
7/19/2023	Teacher Retirement System of Texas	15,709	$0.50M	0.0%	-9.5%	0.021%
7/18/2023	Allspring Global Investments Holdings LLC	2,506	$80K	0.0%	+29.7%	0.003%
7/11/2023	Harbor Capital Advisors Inc.	26,119	$0.83M	0.2%	N/A	0.034%
7/10/2023	ARK Investment Management LLC	8,382,595	$267.66M	1.8%	-2.2%	10.998%
7/6/2023	Green Alpha Advisors LLC	12,491	$0.40M	0.3%	+21.7%	0.016%
5/26/2023	ProShare Advisors LLC	12,940	$0.40M	0.0%	-13.2%	0.017%
5/23/2023	Capital Impact Advisors LLC	12,600	$0.39M	0.5%	+3.7%	0.017%
5/22/2023	University of Texas Texas AM Investment Managment Co.	59,839	$1.83M	0.7%	N/A	0.079%
5/18/2023	JPMorgan Chase & Co.	722,135	$22.11M	0.0%	-2.6%	0.947%
5/18/2023	New York State Common Retirement Fund	45,092	$1.38M	0.0%	-18.6%	0.059%
5/16/2023	Mercer Global Advisors Inc. ADV	7,830	$0.24M	0.0%	N/A	0.010%
5/16/2023	State Street Corp	3,236,088	$99.09M	0.0%	+4.6%	4.246%
5/16/2023	Squarepoint Ops LLC	46,509	$1.42M	0.0%	+74.5%	0.061%
5/16/2023	Geode Capital Management LLC	1,202,329	$36.82M	0.0%	+4.3%	1.578%
5/16/2023	Gilder Gagnon Howe & Co. LLC	107,811	$3.30M	0.1%	-0.3%	0.141%
5/15/2023	Schonfeld Strategic Advisors LLC	34,065	$1.04M	0.0%	+67.0%	0.046%
5/15/2023	Cubist Systematic Strategies LLC	15,744	$0.48M	0.0%	-67.0%	0.021%
5/15/2023	EcoR1 Capital LLC	198,591	$6.08M	0.2%	N/A	0.266%
5/15/2023	Two Sigma Advisers LP	24,900	$0.76M	0.0%	-46.3%	0.033%
5/15/2023	Two Sigma Investments LP	61,300	$1.88M	0.0%	N/A	0.082%
5/15/2023	Deutsche Bank AG	66,030	$2.02M	0.0%	+26.0%	0.088%
5/15/2023	Ensign Peak Advisors Inc	28,330	$0.87M	0.0%	+11.0%	0.038%
5/15/2023	Price T Rowe Associates Inc. MD	30,569	$0.94M	0.0%	+3.3%	0.041%
5/15/2023	Temasek Holdings Private Ltd	4,094,512	$125.37M	0.7%	+42.3%	5.483%
5/15/2023	Hood River Capital Management LLC	237,607	$7.28M	0.2%	+2.7%	0.318%
5/15/2023	Granahan Investment Management LLC	136,137	$4.17M	0.1%	-16.9%	0.182%
5/15/2023	Farallon Capital Management LLC	3,431,921	$105.09M	0.6%	+0.9%	4.596%
5/15/2023	XTX Topco Ltd	7,262	$0.22M	0.0%	N/A	0.010%
5/12/2023	Stifel Financial Corp	7,022	$0.22M	0.0%	+5.1%	0.009%
5/12/2023	BlackRock Inc.	5,290,672	$162M	0.0%	+1.0%	7.085%
5/12/2023	Bank of America Corp DE	377,620	$11.56M	0.0%	+130.1%	0.506%
5/12/2023	UBS Group AG	53,285	$1.63M	0.0%	-61.6%	0.071%
5/12/2023	WINTON GROUP Ltd	8,847	$0.27M	0.0%	N/A	0.012%
5/12/2023	NewEdge Advisors LLC	1,070	$33K	0.0%	-23.4%	0.001%
5/12/2023	Pearl River Capital LLC	14,676	$0.45M	0.1%	+37.9%	0.020%
5/12/2023	Dimensional Fund Advisors LP	180,371	$5.52M	0.0%	+45.0%	0.242%
5/12/2023	ProShare Advisors LLC	12,940	$0.40M	0.0%	-13.2%	0.017%
5/12/2023	Charles Schwab Investment Management Inc.	463,614	$14.20M	0.0%	+0.5%	0.621%

Data available starting January 2016

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of refractory T-cell acute lymphoblastic leukemia/T cell lymphoblastic lymphoma; BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a; and BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease; and the Institute of Molecular and Clinical Ophthalmology Basel for treatment of impaired vision and blindness. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.

Today's Range

Now: $24.05

$23.77

$24.68

50 Day Range

MA: $25.47

$23.01

$32.46

52 Week Range

Now: $24.05

$22.52

$54.30

Volume

903,775 shs

Average Volume

866,067 shs

Market Capitalization

$1.90 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.62

Who are the company insiders with the largest holdings of Beam Therapeutics?: Beam Therapeutics' top insider investors include:
John M Evans (CEO)
Giuseppe Ciaramella (Insider)
Amy Simon (Insider)
Terry-Ann Burrell (CFO)
Fmr Llc (Insider)
Learn More about top insider investors at Beam Therapeutics.